These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5551572)

  • 21. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up on the use of diazepam in the treatment of spasticity.
    Peirson GA; Fowlks EW; King PS
    Am J Phys Med; 1968 Jun; 47(3):143-9. PubMed ID: 5301542
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin in patients with multiple sclerosis.
    Kabus C; Hecht M; Japp G; Jost WH; Pöhlau D; Stuckrad-Barre S; Winterholler M
    J Neurol; 2006 Feb; 253 Suppl 1():I26-8. PubMed ID: 16477482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diazepam in the treatment of spasticity. A preliminary quantitative evaluation.
    Evine IM; Jossmann PB; Friend DG; DeAngelis V; Kane M
    J Chronic Dis; 1969 Jun; 22(1):57-62. PubMed ID: 5794241
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 29. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The action of chlorproethazine on spasticity.
    Matthews WB
    Brain; 1965 Dec; 88(5):1057-64. PubMed ID: 5324919
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration of relaxation after intramuscular neurolysis with phenol.
    Halpern D; Meelhuysen FE
    JAMA; 1967 Jun; 200(13):1152-4. PubMed ID: 6071675
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis.
    Rossier P; van Erven S; Wade DT
    Eur J Neurol; 2000 Nov; 7(6):741-4. PubMed ID: 11136367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of spasticity in children with cerebral palsy.
    Verrotti A; Greco R; Spalice A; Chiarelli F; Iannetti P
    Pediatr Neurol; 2006 Jan; 34(1):1-6. PubMed ID: 16376270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Horne ML
    JAMA; 1976 Jan; 235(3):251. PubMed ID: 946040
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of spasticity by alcoholization of motor points].
    Susset V; Bedoiseau M
    Union Med Can; 1976 May; 105(5):697-700. PubMed ID: 936345
    [No Abstract]   [Full Text] [Related]  

  • 38. [Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].
    Jerusalem F
    Nervenarzt; 1968 Nov; 39(11):515-7. PubMed ID: 4884753
    [No Abstract]   [Full Text] [Related]  

  • 39. [Levamisole treatment in multiple sclerosis and spastic pyramidal syndromes].
    Truşcă E; Stoica I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):125-35. PubMed ID: 6216567
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES; Soll RW; Loewenson RB
    JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.